Andrew J. Fromkin - 10 Aug 2021 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Director
Signature: /s/ Pamela Yanchik Connealy, attorney-in-fact for Andrew J. Fromkin
Issuer symbol: IMVT
Transactions as of: 10 Aug 2021
Net transactions value: +$43,450
Form type: 4
Filing time: 11 Aug 2021, 14:12:40 UTC
Next filing: 12 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Purchase	$43,450	+5,500	+14%	$7.90	45,700	10 Aug 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.